vs
FTAI Infrastructure Inc.（FIP）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是FTAI Infrastructure Inc.的1.7倍（$321.1M vs $188.4M），MADRIGAL PHARMACEUTICALS, INC.净利率更高（-18.2% vs -79.7%，领先61.5%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 95.9%）
FTAI基础设施有限公司持有、运营并投资交通物流、中游能源、发电等核心领域的优质关键基础设施资产，主要面向北美市场，聚焦拥有稳定长期现金流、合同约定收入流的项目，为利益相关方创造可持续回报。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
FIP vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.7倍
$188.4M
营收增速更快
MDGL
高出114.9%
95.9%
净利率更高
MDGL
高出61.5%
-79.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $188.4M | $321.1M |
| 净利润 | $-150.2M | $-58.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -18.6% |
| 净利率 | -79.7% | -18.2% |
| 营收同比 | 95.9% | 210.8% |
| 净利润同比 | -387.6% | 1.4% |
| 每股收益（稀释后） | $-1.32 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FIPMDGL
| Q1 26 | $188.4M | — | ||
| Q4 25 | $143.5M | $321.1M | ||
| Q3 25 | $140.6M | $287.3M | ||
| Q2 25 | $122.3M | $212.8M | ||
| Q1 25 | $96.2M | $137.3M | ||
| Q4 24 | $80.8M | $103.3M | ||
| Q3 24 | $83.3M | $62.2M | ||
| Q2 24 | $84.9M | — |
净利润FIPMDGL
| Q1 26 | $-150.2M | — | ||
| Q4 25 | $-97.7M | $-58.6M | ||
| Q3 25 | $-104.5M | $-114.2M | ||
| Q2 25 | $-70.0M | $-42.3M | ||
| Q1 25 | $120.2M | $-73.2M | ||
| Q4 24 | $-124.7M | $-59.4M | ||
| Q3 24 | $-43.0M | $-107.0M | ||
| Q2 24 | $-48.1M | — |
毛利率FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 96.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | -45.7% | -18.6% | ||
| Q3 25 | -70.8% | -39.7% | ||
| Q2 25 | -56.4% | -22.2% | ||
| Q1 25 | 81.8% | -57.8% | ||
| Q4 24 | -152.7% | -64.8% | ||
| Q3 24 | -51.7% | -187.1% | ||
| Q2 24 | -56.4% | — |
净利率FIPMDGL
| Q1 26 | -79.7% | — | ||
| Q4 25 | -68.1% | -18.2% | ||
| Q3 25 | -74.4% | -39.8% | ||
| Q2 25 | -57.2% | -19.9% | ||
| Q1 25 | 125.0% | -53.4% | ||
| Q4 24 | -154.4% | -57.5% | ||
| Q3 24 | -51.6% | -172.0% | ||
| Q2 24 | -56.7% | — |
每股收益（稀释后）FIPMDGL
| Q1 26 | $-1.32 | — | ||
| Q4 25 | $-1.04 | $-2.55 | ||
| Q3 25 | $-1.38 | $-5.08 | ||
| Q2 25 | $-0.73 | $-1.90 | ||
| Q1 25 | $0.89 | $-3.32 | ||
| Q4 24 | $-1.21 | $-2.50 | ||
| Q3 24 | $-0.45 | $-4.92 | ||
| Q2 24 | $-0.52 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.9M | $198.7M |
| 总债务越低越好 | — | $339.9M |
| 股东权益账面价值 | $-122.5K | $602.7M |
| 总资产 | $5.7B | $1.3B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资FIPMDGL
| Q1 26 | $37.9M | — | ||
| Q4 25 | $57.4M | $198.7M | ||
| Q3 25 | $34.7M | $295.7M | ||
| Q2 25 | $33.6M | $186.2M | ||
| Q1 25 | $26.3M | $183.6M | ||
| Q4 24 | $27.8M | $100.0M | ||
| Q3 24 | $20.3M | $232.7M | ||
| Q2 24 | $33.1M | — |
总债务FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | $3.8B | $339.9M | ||
| Q3 25 | $3.7B | $339.8M | ||
| Q2 25 | $3.1B | $118.4M | ||
| Q1 25 | $2.8B | $118.0M | ||
| Q4 24 | $1.6B | $117.6M | ||
| Q3 24 | $1.5B | $117.1M | ||
| Q2 24 | $1.6B | — |
股东权益FIPMDGL
| Q1 26 | $-122.5K | — | ||
| Q4 25 | $21.3M | $602.7M | ||
| Q3 25 | $181.1M | $625.7M | ||
| Q2 25 | $375.5M | $696.0M | ||
| Q1 25 | $476.2M | $710.6M | ||
| Q4 24 | $202.7M | $754.4M | ||
| Q3 24 | $370.8M | $777.2M | ||
| Q2 24 | $394.8M | — |
总资产FIPMDGL
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.7B | $1.3B | ||
| Q3 25 | $5.5B | $1.4B | ||
| Q2 25 | $4.4B | $1.0B | ||
| Q1 25 | $4.1B | $996.6M | ||
| Q4 24 | $2.4B | $1.0B | ||
| Q3 24 | $2.4B | $1.1B | ||
| Q2 24 | $2.5B | — |
负债/权益比FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | 176.99× | 0.56× | ||
| Q3 25 | 20.59× | 0.54× | ||
| Q2 25 | 8.21× | 0.17× | ||
| Q1 25 | 5.79× | 0.17× | ||
| Q4 24 | 7.84× | 0.16× | ||
| Q3 24 | 4.14× | 0.15× | ||
| Q2 24 | 3.94× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-69.4M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-133.8M |
| 自由现金流率自由现金流/营收 | — | -41.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FIPMDGL
| Q1 26 | $-69.4M | — | ||
| Q4 25 | $-2.8M | $-133.5M | ||
| Q3 25 | $-24.4M | $79.8M | ||
| Q2 25 | $-5.2M | $-47.1M | ||
| Q1 25 | $-85.7M | $-88.9M | ||
| Q4 24 | $-8.1M | $-104.5M | ||
| Q3 24 | $14.2M | $-67.0M | ||
| Q2 24 | $-17.6M | — |
自由现金流FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | $-68.6M | $-133.8M | ||
| Q3 25 | $-90.7M | $79.0M | ||
| Q2 25 | $-87.5M | — | ||
| Q1 25 | $-151.7M | — | ||
| Q4 24 | $-34.3M | $-104.7M | ||
| Q3 24 | $-11.7M | $-67.8M | ||
| Q2 24 | $-32.1M | — |
自由现金流率FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | -47.8% | -41.7% | ||
| Q3 25 | -64.5% | 27.5% | ||
| Q2 25 | -71.6% | — | ||
| Q1 25 | -157.7% | — | ||
| Q4 24 | -42.4% | -101.3% | ||
| Q3 24 | -14.0% | -109.0% | ||
| Q2 24 | -37.9% | — |
资本支出强度FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | 45.9% | 0.1% | ||
| Q3 25 | 47.2% | 0.3% | ||
| Q2 25 | 67.3% | 0.0% | ||
| Q1 25 | 68.6% | 0.0% | ||
| Q4 24 | 32.5% | 0.2% | ||
| Q3 24 | 31.1% | 1.3% | ||
| Q2 24 | 17.2% | — |
现金转化率FIPMDGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIP
暂无分部数据
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
